Gao, Shuai-Shuai Wang, Yan-Jun Zhang, Guo-Xun Zhang, Wen-Ting
Published in
Journal of Bone Oncology
Background Multiple myeloma (MM) is the second incurable hematological malignancy. In recent years, due to the rise of microRNA (miRNA), many scholars have participated in the study of its value in the diagnosis of MM, and have obtained good but inconsistent results. Therefore, in order to determine the role of miRNA in the early diagnosis of MM, w...
Wang, Chao Li, Ming Wei, Rong Wu, Junlong
Published in
Journal of Bone Oncology
Aim We sought to investigate the efficacy of adoptive transfer of TILs plus anti-PD1 therapy in metastatic osteosarcoma patients. Materials and methods A total of 30 patients received anti-PD1 therapy (Group 1) while 30 patients were subjected to TILs plus anti-PD1 therapy (Group 2). Progression-free survival time (PFS) and overall survival time (O...
Wang, Q. Liu, W. Fan, J. Guo, J. Shen, F. Ma, Z. Ruan, C. Guo, L. Jiang, M. Zhao, Y.
...
Published in
Journal of Bone Oncology
von Willebrand factor (VWF) is exclusively expressed in endothelial cells (ECs) and megakaryocytes, which plays a crucial role in the initiation of arterial thrombosis. Recent studies have shown that VWF is also expressed in osteosarcoma (OS) cells and participates in adhesion of cancer cells to platelets, thus promoting metastasis of OS cells. How...
Liang, Shoulei Li, Yong Liu, Hongtao Wang, Baocang
Published in
Journal of Bone Oncology
Objectives Giant cell tumors of bone (GCT) are benign with a local recurrence rate of approximately 20–50%. Growing evidence suggests that inflammation plays an important role in tumor formation and progression. Inflammatory biomarkers, including prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte rat...
Zhong, Jingyu Hu, Yangfan Si, Liping Geng, Jia Xing, Yue Jiao, Qiong Zhang, Huizhen Yao, Weiwu
Published in
Journal of bone oncology
Small cell osteosarcoma (SCOS) is a rare subtype of osteosarcoma, with limited studies mainly focusing on histological features. Our study aims to analyze our own patients and those reported in the literature to increase the recognition of this rare disease, to evaluate patient survival and to further determine potential prognostic factors. Twenty ...
Hayashi, Katsuhiro Yamamoto, Norio Takeuchi, Akihiko Miwa, Shinji Igarashi, Kentaro Higuchi, Takashi Abe, Kensaku Taniguchi, Yuta Aiba, Hisaki Araki, Yoshihiro
...
Published in
Journal of bone oncology
There are several options for biological reconstruction after bone tumor resection. If the tumor invades an epiphysis, the reconstruction is far more complicated because there is no option to restore large joint cartilage using currently available medical techniques. Frozen autograft with liquid nitrogen has been used as recycled autologous bone gr...
Li, Xiaomeng Wu, Ning Zhang, Wenjie Liu, Ying Ming, Yue
Published in
Journal of bone oncology
Both bone metastases and multiple myeloma (MM) are malignant diseases that can appear osteolytic on imaging and are difficult to differentiate. While positron emission tomography/computed tomography (PET/CT) has been demonstrated useful for the diagnosis of various bone lesions, correlations between PET/CT and histopathology and these diseases are ...
Xu, Daoliang Wang, Ben Chen, Lijie Zhang, Huawei Wang, Xiangyang Chen, Jiaoxiang
Published in
Journal of bone oncology
In recent years, studies on bone lymphoma and its histologic types have reached a mature stage. However, reports on the incidence and incidence-based mortality trends of bone lymphoma are scanty. Patients with bone lymphoma in the U.S. were selected from Surveillance, Epidemiology, and End Results (SEER) database (1975-2016), and categorized based ...
Liu, Shuzhong Song, An Zhou, Xi Huo, Zhen Yao, Siyuan Yang, Bo Liu, Yong Wang, Yipeng
Published in
Journal of bone oncology
Advanced breast cancer commonly metastasises to bone; however, the molecular mechanisms underlying the affinity for breast cancer cells to bone remains unclear. Thus, we developed nomograms based on a competing endogenous RNA (ceRNA) network and analysed tumour-infiltrating immune cells to elucidate the molecular pathways that may predict prognosis...
Lei, Yong Junxin, Chen Yongcan, Huang Xiaoguang, Liu Binsheng, Yu
Published in
Journal of Bone Oncology
Osteosarcoma (OS) is the most common primary bone tumour, with a peak incidence in adolescents, and the five-year survival rate of patients with metastasis or recurrence is much lower than that of patients without metastasis and recurrence. OS is initiated and develops in a complex tumour microenvironment (TME) that contains many different componen...